002755.SZ
Beijing Aosaikang Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.25
+3.64%Year over year
Reported trailing growth
- Revenue
- -4.7%
- EBITDA
- —
- EBIT
- +74.0%
- EPS
- +43.0%
- Free cash flow
- +41.0%
- Operating cash flow
- +62.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.7%
- EBITDA
- +56.9%
- EBIT
- +62.3%
- Net income
- +47.6%
- EPS
- +47.1%
- Free cash flow
- +180.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026